SSRIs and other antidepressants increase BDNF over time, so combining them with exogenous BDNF modulators could theoretically produce additive or unpredictable effects
Kato H, Nagai Y, Ohta A, Tenjin A, Nakamura Y, Tsukiyama H, et al
Risks of Intermittent Fasting and Semaglutide Combination Combining intermittent fasting with semaglutide, a glucagon-like peptide-1 receptor agonist used for the treatment of type 2 diabetes and obesity, may present several risks
Remember, its important to tailor your discontinuation strategy to your individual needs, so be sure to consult with your healthcare provider for personalized guidance
The problem here is that it is rapidly broken down by enzymes in the gut called gamma-glutamyltranspeptidases , thus minimising its absorption (25)
Chen, C., Zhou, R., Fu, F